Medical ethics for the genome world a paper from the 2007 William Beaumont hospital symposium on molecular pathology

Journal of Molecular Diagnostics

Volumn 10, Issue 5, 2008, Pages 377-382

  Ormond, Kelly E ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOM SYNDROME; CASE REPORT; CONFIDENTIALITY; DECISION MAKING; FANCONI ANEMIA; FEMALE; FETUS RISK; GAUCHER DISEASE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE QUALITY; HUMAN; HUNTINGTON CHOREA; HYPOTHESIS; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LAW; MALE; MEDICAL ETHICS; MOLECULAR GENETICS; PATIENT INFORMATION; PROCESS MONITORING; REVIEW; SOCIAL ATTITUDE; TAY SACHS DISEASE;

EID: 52249092159     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2008.070162     Document Type: Review

References (28)

1. Simpson JL, Elias S: Genetics in Obstetrics and Gynecology, ed 3. Philadelphia, Saunders, 2003
2. Ciarleglio LJ, Bennett RL, Williamson J, Mandell JB, Marks JH: Genetic counseling through the lifecycle. J Clin Invest 2003, 112:1280-1286
3. Bennett RL, Hampel HL, Mandell JB, Marks JH: Genetic counselors: translating genomic science into clinical practice. J Clin Invest 2003, 112:1274-1279
4. Lucast EK: Informed consent and the misattributed paternity problem in genetic counseling. Bioethics 2007, 21:41-50
5. Ormond KE, Mills PL, Lester LA, Ross LF: Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet C Semin Med Genet 2003, 119:70-77
6. Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E: Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A 2003, 118:201-209
7. Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G: Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 2006, 165:91-97
8. Valverde KD: Why me? Why not me? J Genet Couns 2006, 15:461-463
9. Kerruish NJ, Campbell-Stokes PL, Gray A, Merriman TR, Robertson SP, Taylor BJ: Maternal psychological reaction to newborn genetic screening for type 1 diabetes. Pediatrics 2007, 120:e324-e335
10. Michie S, Bobrow M, Marteau TM: On behalf of the FAP Collaborative Research Group: predictive genetic testing in children and adults: a study of emotional impact. J Med Genet 2001, 38:519-526
11. Green J, Richards M, Murton F, Statham H, Hallowell N: Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns 1997, 6:45-60
12. Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE: Sharing BRCA1/2 test results with first degree relatives: factors predicting who women tell. J Clin Oncol 2006, 24:700-706
13. Jonsen AR, Siegler M, Winslade WJ: Clinical Ethics, ed 4. San Francisco, McGraw Hill, 1998
14. Beauchamp TL, Childress JF (2008). Principles of Biomedical Ethics. 6th ed. Oxford University Press. New York, NY
15. Jonsen AR, Toulmin S (1998). The abuse of casuistry: A history of moral reasoning. University of California Press. Berkely, CA
16. Lidz CW, Applebaum PS, Meisel A: Two models of implementing informed consent. Arch Intern Med 1988, 148:1385-1389
17. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research: Making Health Care Decisions. Washington, DC, GPO, 1982
18. Ormond KE, Iris M, Banuvar S, Minogue J, Annas GJ, Elias S: What do patients prefer: informed consent models for genetic carrier testing. J Genet Couns 2007, 6:539-550
19. Benjamin CM, Adam S, Wiggins S, Theilmann JL, Copley TT, Bloch M, Squitien F, McKellin W, Cox S, Brown SA, Kremer HPH, Burgess M, Meshino W, Summers A, Macgregor D, Buchanan J, Greenberg C, Carson N, Ives E, Frecker M, Welch JP, Fuller A, Rosenblatt D, Miller S, Dufrasne S, Roy M, Anderman E, Prevost C, Khalifa M, Girard K, Taylor S, Hunter A, Goldsmith C, Whelan D, Eisenberg D, Sultan H, Kane J, Shokeir MHK, Gibson A, Cardwell S, Bamforth S, Graver S, Suchowersky O, Klimek M, Garber T, Gardner HA, MacLeod P, Hayden MR: Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet 1994, 55:606-617
20. Harper PS, Newcombe RG: Age at onset and life table risks in genetic counseling for Huntington's disease. J Med Genet 1992, 29:239-242
21. Tarasoff v the Regents of the University of California, 551 P 2d 334 (Cal 1976)
22. Pate v Threlkel, 661 So 2d 278 (Fla 1995)
23. Safer v Estate of Pack, 677 A2d 1188 (NJ App), appeal denied, 683 A2d 1163 (NJ 1996)
24. Offit K, Groeger E, Turner S, Wadsworth EA, Weiser MA: The "duty to warn" a patient's family members about hereditary disease risks. JAMA 2004, 292:1469-1473
25. Apse KA, Biesecker BB, Giardiello FM, Fuller BP, Bernhardt BA: Perceptions of genetic discrimination among at risk relatives of colorectal cancer patients. Genet Med 2004, 6:510-516
26. Clayton EW: Ethical, legal and social Issues of genomic medicine. N Engl J Med 2003, 349:562-569
27. Cho MK, Illangasekare S, Weaver MA, Leonard DG, Merz JF: Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003, 5:3-8
28. Smaglick P: Tissue donors use their Influence in deal over gene patent terms. Nature 2000, 407:821